Moderna Launches First Human Trial for Bundibugyo Ebola Vaccine, Pledges Doses for Low-Income Countries

Summary

Moderna has initiated its first human trial for a Bundibugyo Ebola vaccine and plans to make at least 500,000 doses available to low- and middle-income countries at access pricing through an agreement with CEPI.